LMF Acquisition Opportunities
Price & Volume
Stats
See moreOpen | $0.61 |
Previous Close | $0.60 |
Day Range | $0.55-$0.61 |
52W Range | $0.30-$4.28 |
Market Cap | $16.8M |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $766,000 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $739,000 |
Diluted EPS | -$1.85 |
News
See moreYahoo Finance • 12 days ago
SeaStar Medical Reports Positive Early Results for QUELIMMUNE Therapy in Pediatric Acute Kidney Injury (AKI) at the 5th International Symposium on Acute Kidney Injury in Children
Yahoo Finance • 16 days ago
SeaStar Medical Reports DSMB Recommendation to Continue the NEUTRALIZE-AKI Pivotal Trial in Adult Acute Kidney Injury
Yahoo Finance • 18 days ago
SeaStar Medical to Present Early SAVE Registry Data of QUELIMMUNE in Pediatric Acute Kidney Injury at the 5th International Symposium on Acute Kidney Injury in Children
Yahoo Finance • last month
SeaStar Medical to Participate in the HC Wainwright 27th Annual Global Investment Conference
About
CEO | Mr. Eric Schlorff |
Address | 3513 Brighton Boulevard, Denver, CO, United States, 80216 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 19 |
